Go to content
Attention:

Registers are temporarily unavailable

Due to technical maintenance, the AFM registers will be unavailable from Friday, October 3, 9:00 PM until Sunday, October 5, 9:00 PM at the latest.

DSM B.V.

DSM B.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

Registration date 04 jul 2008 - 09:34
Statutory name DSM B.V.
Title DSM - Repurchase of shares (week 27)
Comments Royal DSM N.V. has repurchased 860,787 of its own shares in the period from 26 June 2008 up to and including 2 July 2008 at an average price of EUR 37.22. This is in accordance with the second phase of the share buyback program, announced on 5 May 2008. The consideration of this repurchase was EUR 32.0 million. The total number of shares repurchased under the second phase of this program to date is 6,080,203 shares for a total consideration of EUR 230.8 million. DSM - the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com. For more information: DSM Corporate Communications Elvira Luykx tel. +31 (0) 45 5782035 fax +31 (0) 45 5740680 e-mail media.relations@dsm.com DSM Investor Relations Hans Vossen tel. +31 (0) 45 5782864 fax +31 (0) 45 5782595 e-mail investor.relations@dsm.com